How many insider declarations has Anderson Woodrow D filed?

Anderson Woodrow D has filed 4 public insider declarations with SEC (Form 4).

What is Anderson Woodrow D's role?

Anderson Woodrow D's reported role is not specified by the regulator across the filings.

Which companies does Anderson Woodrow D report trades for?

Anderson Woodrow D reports trades for 2 companies, including Indivior Pharmaceuticals, Inc..

What is Anderson Woodrow D's declared buy vs sell volume?

Across the available history, declared buys total 93k€ and disposals 0.

← Executives ★ Sign in to follow

AW

Anderson Woodrow D

OFFICERM

·SEC (Form 4)

Indivior Pharmaceuticals, Inc.Indivior Pharmaceuticals, Inc.

0

Total declarations

0

Companies

€93,105

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

2

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the detailed record of transactions filed by Anderson Woodrow D. Insider active across 2 companies, notably Indivior Pharmaceuticals, Inc.. In total, 4 disclosures have been recorded. Split: 2 buys · 0 sell. Total volume traded: €93k. History available since 10 February 2026. The latest transaction was filed on 27 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Anderson Woodrow D

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Indivior Pharmaceuticals, Inc. (US)Indivior Pharmaceuticals, Inc. (US)

Declarations4 total

▲

Anderson Woodrow D

Chief Accounting OfficerExecutives27 Aug 2026Indivior Pharmaceuticals, Inc.

$53,5350SEC ↗

1,500 shares@ US$35.69Common StockSEC:0002014440-26-000012:0

Canonical exit: 25 Nov 2026 (T+90)

▲

Anderson Woodrow D

Chief Accounting OfficerExecutives5 Aug 2026Indivior Pharmaceuticals, Inc.

$54,42037SEC ↗

1,500 shares@ US$36.280.0013% mcap100.0% of flowCommon StockSEC:0002014440-26-000010:0

Canonical exit: 3 Nov 2026 (T+90)

◇

Anderson Woodrow D

Chief Accounting OfficerExecutives3 Mar 2026Indivior Pharmaceuticals, Inc.

0SEC ↗

18,364 sharesCommon StockSEC:0002014440-26-000007:0

◆

Anderson Woodrow D

Chief Accounting OfficerExecutives10 Feb 2026Indivior Pharmaceuticals, Inc.

0SEC ↗

6,903 shares0Common StockSEC:0002014440-26-000005:0

4 of 4 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

AW

Anderson Woodrow D

OFFICERM

·SEC (Form 4)

Indivior Pharmaceuticals, Inc.Indivior Pharmaceuticals, Inc.

0

Total declarations

0

Companies

€93,105

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

2

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the detailed record of transactions filed by Anderson Woodrow D. Insider active across 2 companies, notably Indivior Pharmaceuticals, Inc.. In total, 4 disclosures have been recorded. Split: 2 buys · 0 sell. Total volume traded: €93k. History available since 10 February 2026. The latest transaction was filed on 27 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.